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This journal is ª The Royal Society ofNanostructures based on monoolein or diolein and
amphiphilic gadolinium complexes as MRI contrast
agents†
Antonella Accardo,a Eliana Gianolio,b Francesca Arena,b Sabine Barnert,c
Rolf Schubert,c Diego Tesauroa and Giancarlo Morelli*a
Highly ordered two or three dimensional mesophases in aqueous solution could be usefully obtained by
using monoolein (MO) or diolein (DO) monomers. Nanostructures (also indicated as nanoparticles, NPs)
of MO or DO containing diﬀerent amounts (1%, 5%, 10% and 20%) of the synthetic amphiphilic
gadolinium complex (C18)2DTPA(Gd) have been prepared and characterized for their relaxometric and
structural behaviors. The nanostructure is found in the 110–200 nm range for all investigated systems,
while the presence of the gadolinium containing monomer produces a partial loss of the cubic
symmetry, as shown by Cryo-TEM images of NPs doped with 10% w/w of (C18)2DTPA(Gd). Gadolinium
containing nanostructures display high relaxivity values (in the 10–15 mM1 s1 range at 25 and
20 MHz, with a further increase at 37 C for DO based NPs), and interesting relaxometric properties for
their possible use as MRI contrast agents. NPs containing 10% w/w of (C18)2DTPA(Gd) (MO3-NPs and
DO3-NPs) have been also derivatized by introducing 3% wt of (C18)2–Peg3000–FA to obtain targeted
aggregates (MO3-NP–FA, DO3-NP–FA). A preferential uptake eﬃciency of DO3-NP–FA in IGROV-1 cells
with respect to DO-NPs without folic acid is observed, especially when cells are incubated with low
concentrations of nanostructures or at short incubation times, thus indicating its potential use as a
target-selective delivery system for MRI contrast agents on tumor cells overexpressing the folate receptor.Introduction
Magnetic resonance imaging (MRI) contrast agents based on
paramagnetic gadolinium complexes are widely used in
biomedical research and clinical diagnosis.1,2 They are essen-
tially low molecular weight compounds that rapidly equilibrate
between the intra and extravascular spaces aer intravenous
administration, improving MRI eﬃcacy and providing physio-
logical information along with the impressive anatomical
details already obtained by magnetic resonance images without
contrast.3–5
In order to obtain gadolinium based contrast agents with
enhanced contrast eﬃcacy and diﬀerent pharmacokinetic
properties, supramolecular aggregates, such as micelles and
liposomes, containing Gd(III) complexes have been recently
proposed as MRI contrast agents.6–9 Liposomes are obtained by
self-assembling aggregation of lipophilic gadoliniumR, University of Naples “Federico II”, Via
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Chemistry 2013complexes, or by their co-aggregation with surfactants; micelles
are based on amphiphilic poly(gadolinium complexes) poly-
mers.10 Moreover aggregates derivatized with bioactive mole-
cules, such as peptides8,11–15 and antibodies,16–19 acting as target
selective MRI contrast agents have also been recently proposed.
In addition to micellar and liposomal systems, amphiphilic
molecules can display a variety of higher order two (2D) or three
(3D) dimensional mesophases in aqueous solution. Phases such
as the 2D inverse hexagonal or the 3D inverse cubic structures
are attractive candidates for biomedical applications because
they are thermodynamically stable in water and they can be
dispersed as stable submicronal sized particles.20 These meso-
phases contain extensive water channel networks and are under
exploration as delivery systems of drugs or contrast agents. The
nanostructures formed by dispersion of the bulk mesophases
can oﬀer substantial advantages with respect to traditional
supramolecular aggregates; in fact they present: (a) much
higher payloads of contrast agent ions compared to micellar
and liposomal systems; (b) an expected increased relaxivity rate
(1/T1), due to the slowing of the tumbling rate of the para-
magnetic ions within the dense and highly ordered packing in
the two and three dimensional networks of the hexagonal and
cubic phases; (c) improved relaxivity values due to the presence
of extensive nano-scale water channels that oﬀer a betterJ. Mater. Chem. B, 2013, 1, 617–628 | 617
Journal of Materials Chemistry B Paperenvironment for diﬀusion and fast exchange between gadoli-
nium coordinated water and bulk water.
Contrast agents based on lanthanide complexes of oleates
and phytanates21–23 or on gadolinium and manganese
complexes of EDTA derivatives of oleic and phytanyl acid,24,25 in
highly ordered two or three dimensional mesophases, have
been recently proposed by Drummond et al.21–25
Here we report on the preparation, structural characteriza-
tion and relaxometric behaviour of new gadolinium based
contrast agents obtained by the co-aggregation of an amphi-
philic gadolinium complex, (C18)2DTPA(Gd), with molar
excesses of monoolein (MO) or diolein (DO) (see Fig. 1). Mon-
oolein and diolein are well known monomers used in the
preparation of highly ordered two or three dimensional meso-
phases in aqueous solution. (C18)2DTPA(Gd) contains the DTPA
chelating agent which is well known to give thermodynamically
stable and kinetically inert complexes with Gd(III) ions; more-
over it shows interesting relaxometric properties both as self-
assembled aggregates and in combination with amphiphilic
peptides.26
Moreover, nanostructures derivatized with a new folate
containing monomer (Fig. 1) have been studied by MRI and
uorescence with the aim to have target selective contrast
agents for cells overexpressing the folate receptor.Fig. 1 Schematic representation of (C18H37)2NCO(CH2)2COLys(DTPA-Gd)CONH
Peg3000–FA] monomers, and of the commercially available monoolein and diolein (
618 | J. Mater. Chem. B, 2013, 1, 617–628Materials and methods
Materials
Protected Na-Fmoc-amino acid derivatives, coupling reagents
and Rink amide p-methylbenzhydrylamine MBHA resin were
purchased from Calbiochem-Novabiochem (Laufelngen,
Switzerland). The DTPA(OtBu)4–OH derivative was purchased
from Chematech (Dijon, France). a-(9-Fluorenylmethyloxy-
carbonyl) amino-u-carboxy poly(ethylene glycol) (Fmoc–NH–
Peg3000–COOH) was purchased from Iris Biotech GmbH
(Marktredwitz, Germany). N,N-Dioctadecylsuccinamic acid was
synthesized according to the literature.27 Monoolein (1-mono-
oleoyl glycerol, MO) and diolein (1,3-di(cis-9-octadecenoyl)glyc-
erol, DO) were purchased from Sigma and had a purity of the
acyl group (oleyl group) >99% and a purity of the ester (mono-
glyceride) >97%. A tri-block copolymer, containing ethylene
oxide (EO) and propylene oxide (PO) groups, with the trade
name Pluronic F127 (PF127) and an approximate formula of
EO98PO57EO98 (average molecular weight of 12 600 gmol
1) was
obtained from BASF Svenska AB (Helsingborg, Sweden).
Rhod-PE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-
(lissamine rhodamine B sulfonyl) (ammonium salt)) was
purchased from Avanti Polar Lipids (Alabaster, AL). All other
chemicals were commercially available from Sigma-Aldrich,2 [(C18)2DTPA(Gd)] and (C18H37)2NCO(CH2)2CO–Peg3000–folic acid [(C18)2–
MO and DO, respectively).
This journal is ª The Royal Society of Chemistry 2013
Paper Journal of Materials Chemistry BFluka (Buchs, Switzerland) or LabScan (Stillorgan, Dublin, Ire-
land) and were used as received unless otherwise stated. All
solutions were prepared by weight using doubly distilled water.
The pH of all solutions was kept constant at 7.4. 1H-NMR
spectra were recorded by using a Varian 400 spectrometer (Palo
Alto, CA USA). LC-MS analyses were performed by using a Fin-
nigan Surveyor MSQ single quadrupole electrospray ionization
(Finnigan/Thermo Electron Corporation San Jose, CA). UV
measurements were performed on a UV-vis Jasco V-5505 spec-
trophotometer equipped with a Jasco ETC-505T Peltier
temperature controller with a 1 cm quartz cuvette (Hellma).
Penicillin–streptomycin mixture, RPMI 1640, fetal bovine
serum (FBS), and 0.25% (w/v) trypsin–0.03% (w/v) EDTA solu-
tion were purchased from Lonza (Lonza Sales AG, Verviers,
Belgium). FFRPMI medium (modied RPMI 1640 medium
without folic acid, vitamin B12 and phenol red) was obtained
from Gibco BRL (MD, USA).
The human ovarian carcinoma cell line IGROV-1, human
myeloid leukemia cell line K562, murine melanoma cell line
B16-F10, and human epithelial cervical carcinoma cell line
HeLa were obtained from American Type Culture Collection
(Manassas, VA).
Chemical synthesis
(C18H37)2NCO(CH2)2COLys(DTPA)CONH2, [(C18)2DTPA], was
synthesized by solid-phase methods and puried by precipita-
tion or HPLC, as previously described.26
(C18H37)2NCO(CH2)2CO–poly(ethylene glycol)3000–folic acid,
(C18)2–Peg3000–FA, was obtained according to the followingScheme 1 Scheme for the solid-phase synthesis of the (C18)2–Peg3000–FA monom
This journal is ª The Royal Society of Chemistry 2013solid-phase procedure (Scheme 1). 0.374 g (0.60 mmol) of Dde–
Lys(Fmoc)–OH activated by 1 equivalent of PyBop and HOBt and
2 equivalents of DIPEA in DMF were coupled twice to Rink-
amide MBHA resin (0.51 mmol g1, 0.15 mmol scale, 0.295 g) by
stirring the slurry suspension for 1 h. The solution was ltered
and the resin was washed with three portions of DMF. The Fmoc
protecting group was removed by two treatments with 2.0 mL of
DMF–piperidine (70/30) mixture. Aer the Fmoc removal, N,N-
dioctadecylsuccinamic acid was coupled using 4 equiv. (0.373 g,
0.60mmol) of the lipophilic compound and HOBt/PyBop/DIPEA
under standard conditions. Coupling reaction was carried out
in 3mL of DMF–DCM (50/50) for 1 h. The yield for aliphatic acid
coupling, monitored by the Kaiser test, was in the range 95–
98%. Thus Dde removal was performed by treatment of the
resin with DMF–hydrazine (98/2). Aer Dde removal from the
lysine residue, the Fmoc–Peg3000–OH linker was coupled
(2 equiv.) overnight by using HATU/DIPEA as activating agents
and DMF as a solvent. Finally Fmoc from the polyethylene glycol
linker was removed under standard conditions and then the
folic acid (2 equivalents) was coupled at the N-terminus of the
Peg moiety resin with a traditional coupling agent, HOBt–PyBop
(2/2 equiv.), in DMF–DCM (50/50) and shaking the mixture for
5 h.28 A small portion of the resin was removed for analysis. For
deprotection and cleavage, the fully protected fragment was
treated with TFA–H2O (98/2). The crude product was precipi-
tated at 0 C, washed several times with small portions of water
and recrystallized from methanol and water. The product was
characterized by 1H-NMR spectroscopy and electrospray
spectrometry.er. Rink-amide resin is schematically represented as an empty circle.
J. Mater. Chem. B, 2013, 1, 617–628 | 619
Journal of Materials Chemistry B PaperESI MS ¼ calc. 4135.5 amu; [M + 3H+]/3 ¼ 1379.5 amu; [M +
4H+]/4 ¼ 1034.9 amu.
1H-NMR (400 MHz, DMSO d6): 8.75 (s, 1H), 7.64 (d, 2H), 6.74
(d, 2H), 4.52 (s, 2H), 4.3 (m, 1H, CH Lys a), 4.28 (dd, 1H), 3.60 (s,
270H), 3.1 (m, 2H, CH2 Lys 3), 3.30–3.27 (m, 2H, N–CH2), 2.8–2.4
(m, 6H), 2.1 (m, 2H), 1.90 (m, 2H, CH2 Lys b), 1.6 (m, 2H, CH2
Lys d), 1.45 (m, 2H, CH2 Lys g), 1.27 (m, 60 CH2 aliphatic), 0.89
(t, 6H, CH3).
Synthesis and DLS analysis of nanostructures
Aqueous dispersions of MO or DO (MO-NPs and DO-NPs)
containing various amounts of (C18)2DTPA(Gd) amphiphilic
gadolinium complex (1%O 20%) were prepared by the method
previously described.4 Briey, MO or DO, PF127, and
(C18)2DTPA(Gd) were weighed and mixed in chloroform. The
weight ratio of PF127 to MO or DO was 15% (w/w). Aer evap-
oration of the solvent, the mixture was further dried in a
vacuum. To the dry lm was added 0.1 M phosphate-buﬀer at
pH 7.4, and the vials were immediately sealed and vortexed for
several seconds to distribute water inside the samples. The
mixture was sonicated in a bath sonicator for 30 min and le
overnight under stirring. Finally solutions were homogenized
by using an ULTRA-TURRAX(IKA T18 basic) for 15 min in ice
at 2.5 Hz. Targeted aggregates containing folic acid were
prepared by introducing 3% wt of (C18)2–Peg3000–FA in the
sample composition (MO3-NP–FA, DO3-NP–FA). The eﬀective
dimensions and surface charges of all MO-NPs and DO-NPs
were measured by using a dynamic light scattering (DLS)
instrument (Zetasizer-3000, Malvern Co., UK). The measure-
ments were performed in phosphate-buﬀered saline solution
(pH 7.4) and carried out in triplicate.
Relaxometric characterization of nanostructures
The proton 1/T1 NMRD proles were measured over a
continuum of magnetic eld strength from 0.00024 to 0.47 T
(corresponding to 0.01–20 MHz proton Larmor Frequency) on a
Stelar Fast Field-Cycling relaxometer (Mede Pavia, Italy). This
relaxometer works under complete computer control with an
absolute uncertainty in 1/T1 of 1%. Data points from 0.47 T
(20 MHz) to 1.7 T (70 MHz) were added to the experimental
NMRD proles and were recorded on the Stelar Spinmaster
spectrometer (Mede Pavia, Italy) with a switchable eld from 20
to 70 MHz, by means of the standard inversion-recovery tech-
nique (16 experiments, 2 scans). A typical 90 pulse width was
4 ms and the reproducibility of the T1 data was 0.5%. The
temperature was kept at 25 C with a Stelar VTC-91 airow
heater (Mede Pavia, Italy) equipped with a copper-constant
thermocouple (uncertainty 0.1 C). Relaxivity data at 20 MHz
were measured on both instruments. Data were tted to the
conventional Solomon–Bloembergen–Morgan theory.
Cryo-TEM images
Cryo-TEM investigations were performed with a LEO 912
OMEGA electron microscope (Zeiss, Oberkochen, Germany)
operating at 120 kV under ‘zero-loss’ conditions. Aer placing a
droplet (approx. 5 ml) of the sample on a copper grid620 | J. Mater. Chem. B, 2013, 1, 617–628(Quantifoil S7/2 Cu 400 mesh, holey carbon lms, Quantifoil
Micro Tools GmbH, Jena, Germany), most of the liquid was
absorbed by a lter paper, so that only a thin (100–500 nm)
liquid lm remained. The sample was then immediately shock-
frozen by plunging it into liquid ethane.29 The vitried sample
was stored at 90 K in liquid nitrogen until it was loaded into a
cryogenic sample holder (D626, Gatan Inc, Pleasanton, USA).
The specimens were examined at 174 C. Digital images were
recorded with Proscan HSC 2 von Oxford instruments (Abing-
don, USA), a “slow scan CCD camera system”, and at minimal
under-focus of the microscope objective lens to provide suﬃ-
cient phase contrast.30,31 Soware: iTEM 5.0 (Build 1054), so
imaging System GmbH, Muenster, Germany.In vitro cellular uptake
Diﬀerent tumor cell lines (IGROV-1, B16-F10, HeLa, and K562)
in FFRPMI (modied RPMI 1640 medium without folic acid,
vitamin B12 and phenol red) were incubated with the same
concentration of DO-NPs or DO-NP–FA for 4 h at 37 C. Aer
this incubation time, the cells were washed three times with
5 mL ice-cold phosphate-buﬀered saline (PBS), detached with
EDTA and, for the acquisition of the MR images, collected in
50 mL of PBS, transferred into glass capillaries that were
centrifuged at 1500g for 5 min and placed in an agar phantom.
The MR-images were acquired by a standard T1-weighted spin-
echo sequence and recorded on an ASPECT M2 System oper-
ating at 1 T. At the end of MRI experiments labeled cells were
quantitatively extracted from glass capillaries, dissolved in 2mL
of PBS and sonicated in order to destroy cellular membranes
and obtain cell lysates. The Rhod-PE concentration was deter-
mined by measuring the emission peak at 594 nm (excitation at
543 nm) with a SpectroFluorometer (Fluoromax-4) and using a
calibration line obtained using standard Rhod-PE solutions
(1 nM O 50 mM).
Then the solutions of labeled cells were freeze-dried and
resuspended in 100 mL. These lysates were treated with 37%HCl
(50 : 50) in sealed vials at 120 C overnight. Upon this treatment
all Gd3+ was solubilized as free aquo-ions. Then, the water
proton R1(1/T1) of these solutions was measured at 20 MHz and
25 C on the Stelar SpinMaster Relaxometer (Mede, Pavia, Italy),
and the Gd3+ concentrations were determined from a calibra-
tion curve obtained using standard GdCl3 solutions (0.01–
2 mM).32 The protein content was determined from cell lysates
by the Bradford method using bovine serum albumin as the
standard.33 One mg of protein corresponds to 4.2  106, 6.3 
106, and 4.5  106 of IGROV-1, B16-F10 and K562 cells,
respectively.Confocal analysis
Ca. 5  105 IGROV-1 (human ovarian adenocarcinoma cell
lines) cells in a medium RPMI 1640 were incubated with 90 mL
of Gd–DO-NPs (0.05 mM of [Rhod]) for 6 h at 37 C. Aer this
incubation time, the cells were washed three times with 5 mL
ice-cold phosphate-buﬀered saline (PBS), and were xed in 4%
paraformaldehyde. Cell preparations were examined byThis journal is ª The Royal Society of Chemistry 2013
Paper Journal of Materials Chemistry Bconfocal laser scanning microscopy (Leica, Exton, PA SP5) with
a 63 (0.90 numerical aperture) oil-immersion objective.Results
Synthesis and structural characterization of nanostructures
Nanostructures (NPs) of MO or DO containing diﬀerent
amounts of (C18)2DTPA(Gd) amphiphilic gadolinium complex
(1%, 5%, 10% and 20%) were prepared and designed as MO1-
NPsOMO4-NPs or DO1-NPsODO4-NPs, respectively. Pluronic
F127 in 15% w/w was also added to the nanostructure compo-
sition; this surfactant acts as a stabilizer of submicron particles
with the bicontinuous cubic phase.34 MO3- and DO3-nano-
structures were also derivatized by introducing 3% wt of
(C18)2–Peg3000–FA to obtain targeted aggregates (MO3-NP–FA,
DO3-NP–FA). Fluorescent nanostructures were obtained by
introducing 0.1% w/w of the uorescent probe Rhod-PE
for cellular studies. The eﬀective composition of all studied
nanostructures is indicated in Table 1.
Structural parameters (particle size and zeta potential)
measured by DLS are reported in Tables 2 and 3. Concerning
MO based nanostructures, the particle size remains in the
expected range (diameter  170 nm) for samples containing
lower amounts of (C18)2DTPA(Gd) (MO1-NPs, MO2-NPs); in
contrast a diameter reduction is observed for nanostructuresTable 1 Composition (weight/weight percentage and molar concentration) of na
Formulation
% w/w
(C18)2DTPA(Gd)
[MO]/
mmol kg1
MO1-NP 1% 51.4
MO2-NP 5% 54.8
MO3-NP 10% 50.3
MO4-NP 20% 46.2
DO1-NP 1% —
DO2-NP 5% —
DO3-NP 10% —
DO4-NP 20% —
MO3-NP–FA 10% 50.5
DO3-NP–FA 10% —
Table 2 Structural parameters (particle size, polydispersity index, and zeta pote
nanostructures containing diﬀerent (C18)2DTPA(Gd) percentages
Formulation
% w/w
(C18)2DTPA(Gd) r1p
a (mM1 s1)
MO1-NP 1% 10.92
MO2-NP 5% 10.51
MO3-NP 10% 10.40
MO4-NP 20% 11.12
DO1-NP 1% 13.17
DO2-NP 5% 12.71
DO3-NP 10% 12.85
DO4-NP 20% 14.33
a Relaxivities were measured by using a Stelar Spin master spectrometer a
This journal is ª The Royal Society of Chemistry 2013containing higher amounts of gadolinium complex (MO3-NPs
and MO4-NPs).35 In contrast, the particle size of DO nano-
structures (around 180 nm) is not aﬀected by the amount of
(C18)2DTPA(Gd). The zeta potential values of all investigated
nanostructures are negative, with values ranging between 25
and 73 mV, as expected for the presence of the anionic
gadolinium complex of DTPA.
The addition of (C18)2–Peg3000–FA and/or Rhod-PE to both
MO3- and DO3-nanostructures does not aﬀect signicantly
their size and zeta potential (Table 3).
Cryo-TEM images of MO3-NPs, MO3-NP–FA, DO3-NPs and
DO3-NP–FA are shown in Fig. 2. In all preparations, vesicles
were found but with a tendency to form complex mesophases.
Fig. 2A shows a typical picture of MO3-NPs, where vesicles tend
to fuse into foamy mesophases. In Fig. 2B (DO3-NPs) the prev-
alent structures are coexisting vesicles and tubules. In Fig. 2C
and D (MO3-NP–FA) vesicles, foamy particles and aggregates of
spoon-like structures are visible. Fig. 2E (DO3-NP–FA) again
shows predominantly larger foamy mesophases.Relaxometric properties of nanostructures
The relaxivity values (r1p), dened as the paramagnetic contri-
bution to the observed relaxation rate normalized to 1 mM
concentration of the paramagnetic probe, of MO- and DO-basednostructures
[DO]/
mmol kg1
[(C18)2DTPA(Gd)]/
mmol kg1
[(C18)2–Peg3000–FA]/
mmol kg1
— 0.16 —
— 0.83 —
— 1.58 —
— 3.21 —
32.3 0.16 —
31.2 0.80 —
29.6 1.60 —
25.5 3.11 —
— 1.56 0.145
29.4 1.61 0.145
ntial) measured by DLS, and relaxivities (per Gd(III) ion) of MO- and DO-based
Particle size (nm)
Polydispersity
index PDI Z potential (mV)
171.45  0.56 0.205  0.035 28.60  0.32
163.75  0.66 0.190  0.033 45.60  0.28
111.25  0.34 0.130  0.025 49.10  0.30
119.15  0.65 0.210  0.018 48.00  0.35
184.45  0.58 0.180  0.025 31.60  0.31
173.21  0.49 0.306  0.020 63.20  0.21
173.42  0.51 0.160  0.026 25.76  0.36
198.25  0.65 0.185  0.032 73.20  0.21
t 20 MHz and room temperature.
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Fig. 2 Cryo-TEM images of nanostructures: (A) MO3-NP; (B) DO3-NP; (C), (D)
MO3-NP–FA; and (E) DO3-NP–FA.
Journal of Materials Chemistry B Papernanostructures containing diﬀerent amounts (1 O 20%) of
(C18)2DTPA(Gd) were measured at 20 MHz and 298 K (Table 2).
For both oleic systems, relaxivity values are quite similar to the
diﬀerent loading values, with a slight increase when the
percentage of the Gd-complex is brought to 20% (Fig. 3a). On
the other hand, when monoolein- and diolein-containing
particles are compared, a signicant diﬀerence (20–30%) in the
respective relaxivity values is observed. A deeper understanding
of the relaxometric processes behind this diﬀerence may be
found in the analysis of the Nuclear Magnetic Relaxation
Dispersion (NMRD) proles in which the relaxivity of a given
system is investigated as a function of the applied magnetic
eld in the range 0.01–70 MHz (Proton Larmor Frequency).
Fig. 3b shows the NMRD proles of MO4-NPs and DO4-NPs,
both containing 20% (C18)2DTPA(Gd), measured at 298 K and
neutral pH. The NMRD proles have been analyzed in terms of
the available theory of paramagnetic relaxation,36–38 and the
main relaxometric parameters have been determined and are
reported in Table 4.
Themain diﬀerence in the two systems seems to rely on their
reorientational correlation times (sR), being six times longer for
DO4-NPs than for MO4-NPs. This behavior is likely related to a
more compact insertion of the Gd-complex, which is function-
alized with two aliphatic chains, in the mesophase scaﬀold
when it is built by diolein lipids instead of monoolein ones.
Relaxivity values associated with diolein- and monoolein-
containing systems were also investigated as a function of
temperature in the range 298 O 343 K at a xed frequency of
20 MHz (Fig. 4). While the relaxivity of MO4-NPs decreases as
the temperature is increased, and in the case of DO4-NPs a bell
shaped prole is obtained. The experimental points have been
interpolated by applying the same Solomon–Bloemergen–
Morgan theory applied for the tting of NMRD proles, and
taking into account the temperature dependence of the involved
relaxation times. The analysis of NMRD proles is the tech-
nique of choice for an accurate determination of sR associated
with paramagnetic species.39 Therefore, for the analysis of
the relaxivity, temperature dependence sR has been xed to
the value determined from NMRD. A very good agreement
from the two sets of independent measures has been obtained
for the principal relaxometric parameters aﬀecting the relaxivity
of the systems considered (Table 3).
Unambiguously, the temperature dependence of the relax-
ivity associated with DO4-NPs indicates that, at 20 MHz and
298 K, the relaxivity of the paramagnetic adduct is signicantly
limited by sM. In fact, the initial observed increase of r1p, as theTable 3 Structural parameters (particle size, polydispersity index, and zeta pote
nanostructures containing 10% (C18)2DTPA(Gd), 0.1% Rhod-PE and 3% (C18)2–Peg
Formulation r1p
a (mM1 s1) Particle size (nm
MO3-NP 10.40 111.25  0.53
MO3-NP–FA 10.00 150.45  0.46
DO3-NP 12.85 173.42  0.88
DO3-NP–FA 13.06 149.42  0.44
a Relaxivities were measured by using a Stelar Spin master spectrometer a
622 | J. Mater. Chem. B, 2013, 1, 617–628temperature increases (in the range 298 O 310 K), may be
accounted for in terms of eqn (1) which shows that, when T1M <
sM (as occurs in the case of DO4-NPs which are endowed with a
very long sR value), the inner-sphere contribution to the
observed relaxivity increases as the exchange of the inner-
sphere water molecule becomes faster:
ris ¼ qC
55:6
1
T1M þ sM (1)
where C is the molar concentration of the Gd-complex, q is the
number of inner sphere water molecules and T1M is the relax-
ation time of the protons of the coordinated water molecule. In
the second part of the curve (in the range 310 O 333 K), the
opposite condition (T1M > sM) is met, and, as T1M has an inverse
proportionality to sR, an increase of temperature causes its
elongation and a consequent decrease in r1p.40ntial) measured by DLS, and relaxivities (per Gd(III) ion) of MO- and DO-based
3000–FA
) Polydispersity index PDI Z potential (mV)
0.130  0.020 49.10  0.32
0.150  0.030 39.60  0.28
0.160  0.030 25.76  0.43
0.120  0.026 27.76  0.50
t 20 MHz and room temperature.
This journal is ª The Royal Society of Chemistry 2013
Fig. 3 (A) Proton longitudinal relaxivities of DO-NPs andMO-NPs, measured at 20MHz and 298 K, as a function of diﬀerent (C18)2DTPA(Gd) loading extent. (B) Proton
Nuclear Magnetic Relaxation dispersion proﬁles of MO4-NP and DO4-NP, containing 20% (C18)2DTPA(Gd), measured at 298 K and neutral pH.
Paper Journal of Materials Chemistry BIn Fig. 4 the eﬀect of temperature on the relaxivity of MO4-
NPs is also reported. The system shows an incipient limiting
eﬀect of sM only at low temperatures, whereas the overall
decrease of r1p versus T is a clear indication of a dominance of
T1M over sM in eqn (1).
The addition of Rhod-PE (0.1% wt) and (C18)2–Peg3000–FA
(3% wt) to both MO- and DO-nanostructure preparations con-
taining 10% (C18)2DTPA(Gd) does not aﬀect signicantly their
relaxivity values (Table 4).Fig. 4 Proton longitudinal relaxation rates of MO4-NPs and DO4-NPs ([Gd] ¼
0.9 mM) measured as a function of temperature at 20 MHz and neutral pH.In vitro cellular uptake
MO- and DO-NPs containing 10% (C18)2DTPA(Gd) and doped
with 0.1% of Rhod-PE have been functionalized for specic cell
recognition through the insertion in the lipid composition of
the amphiphilic folic acid containing molecules (MO3-NP–FA
and DO3-NP–FA).
Folic acid, an oxidized form of folate, is an attractive tar-
geting ligand due to its high binding aﬃnity for the folate
receptors (Kd  1010 M) overexpressed on many tumor cells.
IGROV-1 cells, an ovarian cancer line which is known to
possess an high expression of folate receptors,41 have been
incubated for 4 hours at 37 C in FFRPMI (modied RPMI 1640
medium without folic acid, vitamin B12 and phenol red) with
diﬀerent concentrations (10–500 mM of Gd) of MO-NP–FA and
DO-NP–FA as well as with the same concentrations of the
unspecic MO-NPs and DO-NPs as a control. A further control
experiment was carried out on a decient folate-receptor
cell line, B16-F10. Either MO-NPs or folate targeted MO-NPsTable 4 Principal relaxometric parameters obtained from the ﬁtting procedure of N
analysis sR has been ﬁxed to the values found from NMRD analysis
Samples
% (C18)2
DTPA(Gd)
D2 (s2) s
NMRD r1p vs. T N
MO4-NP 20% (1.44  0.08)  1019 (1.01  0.22)  1019 4
DO4-NP 20% (9.79  0.65)  1018 (9.85  0.86)  1018 4
This journal is ª The Royal Society of Chemistry 2013(MO-NP–FA) resulted to be highly toxic for cells even at the
lower concentration values (data not shown). Thus, for the
following in vitro cellular experiments, only diolein-nano-
structures were considered.
Cellular uptake was quantied by measuring either the
Gd(III) or the rhodamine content normalized to 1 mg of protein
in the cellular lysates (Fig. 5a and b). Aer the uptake time (4 h
at 37 C) cells were extensively washed, collected in phosphate-
buﬀered saline (PBS) and sonicated to induce cell lysis. TheMRD proﬁles shown in Fig. 3B and r1p vs. T proﬁles shown in Fig. 4. In r1p vs. T data
V (ps)
sR (ps)
sM (ms)
MRD r1p vs. T NMRD r1p vs. T
2.1  1.46 41.2  1.33 580  76 1.09  0.13 1.16  0.08
2.1  1.27 41.9  1.24 3470  611 1.28  0.019 1.42  0.06
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Fig. 5 Gd(III) (a) and Rhod-PE (b) contents of IGROV-1 (stars) and B16F10 (squares) cells measured through relaxometry and ﬂuorescence respectively, after the
incubation for 4 h at 37 Cwith folic acid containing DO-NP–FA (black symbols) and DO-NPs without folic acid (white symbols); (c) T1-weightedMR-image of a phantom
containing IGROV-1 cells labeled with diﬀerent concentrations (20–100 mM) of DO-NP–FA (2,3,4) and DO-NPs (5,6,7); (d) comparison of the amount of Gd(III) accu-
mulated from IGROV-1 cells incubated with DO-NP–FA (Gd(III) concentration 20 mM) for 4 h at 37 C and for 1 h at 4 C. The amount of internalized Gd(III) with the same
amount of DO-NPs without folic acid for 4 h at 37 C is also reported.
Journal of Materials Chemistry B PaperRhod concentration was determined by measuring the uores-
cence emission peak at 594 nm. For the Gd(III) quantication, a
relaxometric based method was used as reported in the Exper-
imental section. We observed a high uptake level in IGROV-1
cells incubated with both targeted DO-NP–FA and not-targeted
DO-NPs. Nevertheless, at low NP concentrations in the incu-
bation media, uptake of folate-containing nanostructures
resulted to be 15–40% higher than the corresponding one
measured with non-targeted DO-NPs. Signicantly lower inter-
nalization values were registered on B16-F10 control cells
(Fig. 5a and b). The same behavior was observed by comparing
the uptake in IGROV-1 cells with that measured in other tumor
cells (K562, and HeLa) with low FA receptor expression (Fig. 6a
and b).
An MRI investigation of IGROV-1 cells labeled with diﬀerent
amounts of DO-NP–FA and DO-NPs was carried out in the range
of Gd(III) concentration 20–100 mM (Fig. 5c). In the T1-weighted
MR-image, labeled cells are markedly hyperintense with respect
to the control unlabeled cells, with an enhancement factor
dependent on the concentration of the paramagnetic probe in
the incubation medium. The signal enhancement of labeled
cells with respect to the control non-labeled ones has been
calculated by using eqn (2):624 | J. Mater. Chem. B, 2013, 1, 617–628Enð%Þ ¼ SIðNPsÞ  SIðcontrolÞ
SIðcontrolÞ  100 (2)
Consistent with the cellular uptake shown in Fig. 5a, T1W
signal enhancements of cells labeled with DO-NP–FA are from
12% (for [Gd] ¼ 100 mM) to 32% (for [Gd] ¼ 20 mM) higher than
the corresponding ones labeled with DO-NPs without folic acid.
When active transport was blocked by conducting the uptake
experiment at 4 C (Fig. 5d) the amount of Gd(III) accumulated
by cells was ca. 50% lower. This amount is similar, within the
experimental error, to that found in cells incubated with non-
targeted DO-NPs at 37 C for 4 h.
Finally, a confocal microscopy analysis of IGROV-1 and
B16-F10 cells incubated with Rhod-PE loaded DO3-NP–FA and
DO3-NPs has been carried out (Fig. 7). The confocal images of
IGROV-1 cells incubated with targeted NPs, when compared
to those treated with untargeted NPs, show a higher uores-
cence intensity at 2 hours of incubation while become similar
aer 4 hours of incubation. For both, but especially for the
FA-containing nanostructures, the red uorescence is local-
ized on the external surface of cells indicating a binding to the
cellular membrane but not a massive internalization of the
probes.This journal is ª The Royal Society of Chemistry 2013
Fig. 6 (a) Gd(III) (black bars) and Rhod-PE (red bars) contents of IGROV-1, Hela, B16-F10 and K562 cells after incubation for 4 h at 37 C with folic acid containing
DO-NP–FA (Rhod-PE concentration 0.03 mM and Gd(III) concentration 50 mM). (b) Fluorescence emission spectra of cell lysates incubated for 4 h at 37 C with DO-NP–FA
(Rhod-PE concentration 0.03 mM) excited at 543 nm. The 594 nm peak corresponding to Rhod-PE emission is clearly visible only in the case of IGROV-1 cells.
Fig. 7 Confocal microscopy analysis of IGROV-1 cells (A–D) incubated for 2 h (left) and 4 h (right) at 37 C with DO-NPs (A and B) and DO-NP–FA (C and D) and
B16F10 cells (E and F) incubated in the same time and temperature conditions with DO-NPs (E) and DO-NP–FA (F). For all the experiments the concentration of Rhod-PE
is 0.05 mM.
Paper Journal of Materials Chemistry BOn the other hand, consistent with cellular uptake results
shown in Fig. 5b and in Fig. 6, any uorescence signal was seen
aer 4 hours of incubation of the folate receptor decient
B16F10 cells incubated with either DO3-NP–FA or DO3-NP.Discussion
Nonlamellar nanostructures are constituted by dispersion of
self-assembled lipid mesophases corresponding to diﬀerent
non-lamellar phase structures such as reversed micellar cubic
(III), reversed hexagonal (HII), reversed bicontinuous cubic (QII)
or “sponges” (L3). Very few systems doped with chelated metal
ions included in the cubic phase framework have been reported
until now.21–25,42 Examples have been reported in which the
paramagnetic ion was included in the nanostructures throughThis journal is ª The Royal Society of Chemistry 2013coordination to oleates or phytanates molecules leading to
systems endowed with considerably low stability and relaxivity
values.21,26 An improvement from the stability point of view has
been obtained for systems containing Gd(III) and Mn(II) ions
complexed with EDTA-monoolein and diolein,22 even if, in the
case of Gd(III) doped systems, the thermodynamic and kinetic
stability toward trans-metallation is not yet high enough to
think of a possible in vivo application. Recently, cubic nano-
structured lipid nanostructures doped with Ni(II)-EDTA-bi-
oleoyl complexes have been characterized.24,25
It is known that highly ordered two or three dimensional
mesophases in aqueous solution could be usefully obtained by
using monoolein and diolein monomers. Anyway, as indicated
by most of the reported cases, the cubic symmetry of the
structure could decrease by increasing the percentage of theJ. Mater. Chem. B, 2013, 1, 617–628 | 625
Journal of Materials Chemistry B Papermetal doping (above 5% mol) and a mixture of uni- and
bi-lamellar vesicles or liposomes can be observed.
Here we report on preparation, structural and relaxometric
behavior, and in vitro binding studies of new gadolinium con-
taining nanostructures. To the best of our knowledge, these are
the rst Gd-containing nanostructured systems displaying
tendency to form complex mesophases, in which the Gd(III)
metal ion is included in a thermodynamically stable complex.
Diﬀerent amounts of the amphiphilic gadolinium complex have
been experienced in the nanostructure preparation (1 O 20%
wt). Moreover MRI nanostructures with potential selectivity
towards the folate receptor (FR), overexpressed on many cancer
types, were prepared by introducing a low amount (3% w/w) of
an amphiphilic derivative of the folic acid ((C18)2–Peg3000–FA).
As expected, doping of MO and DO nanostructures with 10%
w/w of gadolinium containing monomer and/or 3% w/w of folic
acid derivative produces a partial loss of cubic symmetry of the
structure as indicated by Cryo-TEM images (Fig. 2) in which
vesicles coexisting with tubules, foamy mesophases and spoon-
like structures are well visible.
Relaxivity values associated with the diﬀerent formulations
of MO- and DO-nanostructures containing 1 to 20 % of
(C18)2DTPA(Gd) do not change in a signicant way by
changing the Gd(III)-complex content, and are quite close to
the value (15.2 mM1 s1 at 20 MHz and 298 K) recently
reported26 for vesicles constituted by the same Gd-complex
mixed with an octreotide-containing monomer ((C18)2L5–Oct)
in a 90 : 10 ratio. This result is indicative of a quite fast
diﬀusion of water molecules inside the channels of the
nanostructure framework which does not infer a kinetic limit
on the observed relaxivity. By comparing MO- and DO-
containing nanostructures, a diﬀerence in their relaxivity
(20–30% higher in the case of DO-NPs) is observed. From the
analysis of the NMRD (Nuclear Magnetic Relaxation Disper-
sion) proles of the two systems, which allows a good esti-
mation of the relaxation parameters governing a given
paramagnetic system, it was found out that the main diﬀer-
ence between the two systems seems to relay on the reor-
ientational correlation times (sR) associated with the
Gd-complex in the two lipid framework, being six times longer
for DO4-NP than for MO4-NP. This behavior is likely related to
a more solid and compact insertion of the Gd-complex, which
is functionalized with two aliphatic chains, in the mesophase
scaﬀold when it is built by diolein lipids instead of monoolein
ones. The longer sR value associated with DO-NPs aﬀects also
the temperature dependence of its relaxivity (Fig. 4). In fact,
while the relaxivity of MO4-NPs decreases as the temperature
is increased, in the case of DO4-NPs a bell shaped prole is
obtained with a further increase in the relaxivity, with respect
to the value measured at 25 C, which reaches a value of
17.0 mM1 s1 at 37 C. Functionalization of MO- and DO-NPs
with the amphiphilic folic acid containing molecule does not
aﬀect the relaxivity of the corresponding nanostructures
(Table 3).
Folate based targeting, which allows a selective delivering
of therapeutic and imaging probes to tumors,43 has been
extensively employed in nuclear medicine,44 uorescence626 | J. Mater. Chem. B, 2013, 1, 617–628imaging of cancer cells,45 and MR-imaging by iron-oxide
nanostructures46 and by Gd-containing liposomes.47 The folate
receptor is overexpressed in many cancer types such as brain,
kidney, lung, and breast cancers, and, in particular, in
epithelial carcinomas such as ovarian cancer.48 Folate targeted
NPs, as well as the corresponding non-targeted ones, have
been tested on IGROV-1 cells, an ovarian carcinoma cell line
which has been proved to possess a very high level of a-FR
expression.41 At the concentration range used in the present
study, MO-containing nanostructures resulted to be highly
toxic for cells. This result is in agreement with literature data
reporting that cubic phase dispersions based on glycerol–
monoolein and diﬀerent surfactants (at diﬀerent lipid to
polymer ratios) show massive hemolysis activity likely due to
its high fusogenicity with respect to lipid mixing with cellular
membranes. In contrast, it is known that glycerol–diolein
based “sponges” show a very small degree of hemolytic activity
(1–2%).49 The hypothesis on the toxicity of monoolein based
nanostructures stabilized with Pluronic F127 (PF127) is that
they behave as a Trojan horse in which monoolein promotes
bioadhesion and internalization of PF127 which, once inside
the cells, may exert its toxic activity toward mitochondrial and
nuclear membranes.50 This could be the case also for MO-NPs
in which PF127 is present as the stabilizer.
The uptake experiments were thus carried out only on
DO-based nanostructures. IGROV-1 uptake eﬃciency of folate
functionalized DO-NPs and folate free DO-NPs was assessed
either by measuring the Gd(III) content or the rhodamine
content in cell lysates. A preferential uptake eﬃciency of DO-
NP–FA in IGROV-1 cells with respect to DO-NPs without folic
acid was observed, especially when cells were incubated with
low concentrations of nanostructures (Fig. 5) or at short incu-
bation times (Fig. 7). Anyway, quite surprisingly, a very high
labeling eﬃciency, in IGROV-1 cells, was found even with
nanostructures lacking the folate vector (DO-NPs). The uo-
rescence intensity per cell measured on IGROV-1 cells labeled
with DO-NP–FA is 20 times higher than that reported47 for KB
cells labelled with folate receptor-targeted bimodal uorescent
paramagnetic liposomes. It may be speculated that DO-NP–FA
accumulation in IGROV-1 cells may be imputed to two distinct
recognition pathways. On one side, the specic recognition of
folate receptors overexpressed on IGROV-1 cells is exploited,
and on the other side an accumulation occurs likely due to the
presence of Pluronic F127 as the particle stabilizer. In fact, it
has been reported that Pluronic-micelles51 and Pluronic-adsor-
bed liposomes52 are internalized by Caco-2 cells via clathrin-
mediated and caveole-mediated endocytosis.
By comparing the uptake eﬃciency of DO-NP–FA and
DO-NPs in other cell types with lower or no expression of
folate receptors (B16F10, K562 and HeLa) we observed a drastic
drop in Gd(III) and rhodamine contents. This behavior is easily
explained in the case of DO-NP–FA, on the basis of the lack of
uptake due to specic folate receptors recognition but remains
unclear in the case of untargeted DO-NPs because the inter-
nalization mechanisms associated with the presence of Plur-
onic F127 should be potentially active on a wide range of
cell lines.This journal is ª The Royal Society of Chemistry 2013
Paper Journal of Materials Chemistry BConclusions
Nanostructures based on monoolein and diolein, well known
monomers used in the preparation of highly ordered two or
three dimensional mesophases in aqueous solution, have
been prepared and doped with diﬀerent amounts of a
synthetic amphiphilic gadolinium complex. Even if, as
expected, the presence of the gadolinium containing mono-
mer produces a partial loss of the cubic symmetry, gadoli-
nium containing nanostructures display high relaxivity
values and interesting relaxometric properties for their
possible use as MRI contrast agents. This is particularly true
in the case of diolein based nanostructures in which higher
relaxivity values, with a further increase at 37 C, are found,
probably due to a more solid and compact insertion of the
gadolinium complex in the mesophase scaﬀold built by dio-
lein lipids.
Moreover gadolinium doped diolein NPs, derivatized on
the external surface by folic acid-containing molecules,
could act as a target-selective delivery system for MRI
contrast agents. In fact, DO-NP–FA shows very low toxicity,
with a degree of hemolytic eﬀect below 2%, and preferential
uptake eﬃciency in IGROV-1 cells expressing the folate
receptor.AbbreviationsDCMThis journal is ª TheDichloromethane;
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